Journal Article (248)
41.
Journal Article
38 (5), p. 238 - 238 (2005)
Is testosterone a substrate of P-glycoprotein in abcb1ab knock out mice? Pharmacopsychiatry 42.
Journal Article
16 (3), pp. 345 - 349 (2005)
The directions of psychiatric research by Emil Kraepelin. History of Psychiatry 43.
Journal Article
38 (5), p. 240 - 240 (2005)
Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry 44.
Journal Article
38 (5), p. 240 - 240 (2005)
Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with agoraphobia and panic attacks. Pharmacopsychiatry 45.
Journal Article
16 (Suppl. 1), p. S88 - S88 (2005)
A key role for hypothalamic AVP in anxiety/depression-related behavior and social recognition: An antisense study. Behavioural Pharmacology 46.
Journal Article
38 (5), pp. 241 - 242 (2005)
Sleep architecture and sleep continuity in healthy twins. Pharmacopsychiatry 47.
Journal Article
38 (5), p. 242 - 242 (2005)
The hormonal hypothesis of RLS revisited - prevalence of RLS in transsexuals. Pharmacopsychiatry 48.
Journal Article
38 (5), p. 249 - 249 (2005)
Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Pharmacopsychiatry 49.
Journal Article
38 (5), p. 249 - 249 (2005)
Ghrelin plasma levels during psychopharmacological treatment. Pharmacopsychiatry 50.
Journal Article
38 (5), pp. 248 - 249 (2005)
Does antidepressant therapy improve glucose metabolism? Pharmacopsychiatry 51.
Journal Article
38 (5), p. 251 - 251 (2005)
Change in HPA system function predicts treatment response in depression. Pharmacopsychiatry 52.
Journal Article
38 (5), p. 251 - 251 (2005)
Altered short-term and long-term plasticity in the dentate gyrus in mice lacking the cannabinoid CB1 receptor. Pharmacopsychiatry 53.
Journal Article
38 (5), p. 253 - 253 (2005)
Effects of the metabotropic glutamate type II receptor agonist LY544344 on panic anxiety induced by cholecystokinin tetrapeptide in healthy volunteers. Pharmacopsychiatry 54.
Journal Article
16 (Suppl. 1), p. S88 - S88 (2005)
Major role for vasopressin in a new mouse model of anxiety and depression. Behavioural Pharmacology 55.
Journal Article
38 (5), p. 254 - 254 (2005)
Proteomic search for intracellular binding sites of antidepressants. Pharmacopsychiatry 56.
Journal Article
38 (5), p. 254 - 254 (2005)
Implications of obesity and medical illness for major depression - a different endophenotype of major depression in obese patients? Pharmacopsychiatry 57.
Journal Article
38 (5), p. 255 - 255 (2005)
Sleep-onset REM sleep in obsessive compulsive disorder. Pharmacopsychiatry 58.
Journal Article
38 (5), p. 259 - 259 (2005)
Effects of TPR proteins on steroid receptor signaling. Pharmacopsychiatry 59.
Journal Article
38 (5), p. 260 - 260 (2005)
MAO-B acitivity in platelets associated with suicide attempts in depressed patients. Pharmacopsychiatry 60.
Journal Article
38 (5), p. 261 - 261 (2005)
Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain - modelling central CRH system hyperactivity. Pharmacopsychiatry